These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 12782567

  • 21. A familial form of conduction defect related to a mutation in the PRKAG2 gene.
    Charron P, Genest M, Richard P, Komajda M, Pochmalicki G.
    Europace; 2007 Aug; 9(8):597-600. PubMed ID: 17483151
    [Abstract] [Full Text] [Related]

  • 22. Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage.
    Luptak I, Shen M, He H, Hirshman MF, Musi N, Goodyear LJ, Yan J, Wakimoto H, Morita H, Arad M, Seidman CE, Seidman JG, Ingwall JS, Balschi JA, Tian R.
    J Clin Invest; 2007 May; 117(5):1432-9. PubMed ID: 17431505
    [Abstract] [Full Text] [Related]

  • 23. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
    Ben Jehuda R, Eisen B, Shemer Y, Mekies LN, Szantai A, Reiter I, Cui H, Guan K, Haron-Khun S, Freimark D, Sperling SR, Gherghiceanu M, Arad M, Binah O.
    Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
    [Abstract] [Full Text] [Related]

  • 24. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome.
    Vaughan CJ, Hom Y, Okin DA, McDermott DA, Lerman BB, Basson CT.
    J Cardiovasc Electrophysiol; 2003 Mar; 14(3):263-8. PubMed ID: 12716108
    [Abstract] [Full Text] [Related]

  • 25. AMP-activated protein kinase: a key stress signaling pathway in the heart.
    Young LH, Li J, Baron SJ, Russell RR.
    Trends Cardiovasc Med; 2005 Apr; 15(3):110-8. PubMed ID: 16039971
    [Abstract] [Full Text] [Related]

  • 26. Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome.
    Miyamoto L.
    J Med Invest; 2018 Apr; 65(1.2):1-8. PubMed ID: 29593177
    [Abstract] [Full Text] [Related]

  • 27. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome.
    Davies JK, Wells DJ, Liu K, Whitrow HR, Daniel TD, Grignani R, Lygate CA, Schneider JE, Noël G, Watkins H, Carling D.
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1942-51. PubMed ID: 16339829
    [Abstract] [Full Text] [Related]

  • 28. Detection and quantification by deformation imaging of the functional impact of septal compared to free wall preexcitation in the Wolff-Parkinson-White syndrome.
    De Boeck BW, Teske AJ, Leenders GE, Mohamed Hoesein FA, Loh P, van Driel VJ, Doevendans PA, Prinzen FW, Cramer MJ.
    Am J Cardiol; 2010 Aug 15; 106(4):539-546.e2. PubMed ID: 20691313
    [Abstract] [Full Text] [Related]

  • 29. [AMP-activated protein kinase: how a mistake in energy gauge causes glycogen storage].
    Ofir M, Hochhauser E, Vidne BA, Freimark D, Arad M.
    Harefuah; 2007 Oct 15; 146(10):770-5, 813-4. PubMed ID: 17990392
    [Abstract] [Full Text] [Related]

  • 30. Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis.
    Oliveira SM, Ehtisham J, Redwood CS, Ostman-Smith I, Blair EM, Watkins H.
    J Mol Cell Cardiol; 2003 Oct 15; 35(10):1251-5. PubMed ID: 14519435
    [Abstract] [Full Text] [Related]

  • 31. The Wolff-Parkinson-White syndrome and its anatomical substrates.
    Becker AE, Anderson RH.
    Anat Rec; 1981 Sep 15; 201(1):169-77. PubMed ID: 7305018
    [Abstract] [Full Text] [Related]

  • 32. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.
    Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS, Ahmad F, Lozado R, Shah G, Fananapazir L, Bachinski LL, Roberts R.
    N Engl J Med; 2001 Jun 14; 344(24):1823-31. PubMed ID: 11407343
    [Abstract] [Full Text] [Related]

  • 33. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.
    Gollob MH, Green MS, Tang AS, Roberts R.
    Curr Opin Cardiol; 2002 May 14; 17(3):229-34. PubMed ID: 12015471
    [Abstract] [Full Text] [Related]

  • 34. [Cardiomyopathies due to defective energy metabolism: morphological and functional features].
    Giordano C, D'Amati G.
    Pathologica; 2005 Dec 14; 97(6):361-8. PubMed ID: 16619977
    [Abstract] [Full Text] [Related]

  • 35. Physiological Expression of AMPKγ2RG Mutation Causes Wolff-Parkinson-White Syndrome and Induces Kidney Injury in Mice.
    Yang X, Mudgett J, Bou-About G, Champy MF, Jacobs H, Monassier L, Pavlovic G, Sorg T, Herault Y, Petit-Demoulière B, Lu K, Feng W, Wang H, Ma LJ, Askew R, Erion MD, Kelley DE, Myers RW, Li C, Guan HP.
    J Biol Chem; 2016 Nov 04; 291(45):23428-23439. PubMed ID: 27621313
    [Abstract] [Full Text] [Related]

  • 36. Human γ2-AMPK Mutations.
    Yavari A, Sarma D, Sternick EB.
    Methods Mol Biol; 2018 Nov 04; 1732():581-619. PubMed ID: 29480501
    [Abstract] [Full Text] [Related]

  • 37. Rare forms of preexcitation: a case study and brief overview of familial forms of preexcitation.
    Koneru JN, Wood MA, Ellenbogen KA.
    Circ Arrhythm Electrophysiol; 2012 Aug 01; 5(4):e82-7. PubMed ID: 22895604
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cardiac manifestations of PRKAG2 mutation.
    Banankhah P, Fishbein GA, Dota A, Ardehali R.
    BMC Med Genet; 2018 Jan 03; 19(1):1. PubMed ID: 29298659
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.